Filing Details
- Accession Number:
- 0001127602-17-034165
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-07 20:21:49
- Reporting Period:
- 2017-12-05
- Accepted Time:
- 2017-12-07 20:21:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189130 | T Jay Flatley | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-12-05 | 5,737 | $210.93 | 505,980 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-05 | 3,294 | $211.88 | 502,686 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-05 | 4,769 | $212.80 | 497,917 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-05 | 4,700 | $214.03 | 493,217 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-05 | 1,300 | $214.71 | 491,917 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-05 | 200 | $215.65 | 491,717 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-05 | 8,159 | $211.06 | 483,558 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 140 | Indirect | By Daughters |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 5,737 shares sold ranging from $210.37 to $211.36 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 3,294 shares sold ranging from $211.37 to $212.29 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 4,769 shares sold ranging from $212.45 to $213.34 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 4,700 shares sold ranging from $213.50 to $214.48 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,300 shares sold ranging from $214.52 to $215.29 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $215.62 to $215.67 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
